RNXT
Price
$1.30
Change
-$0.06 (-4.41%)
Updated
Jun 13 closing price
Capitalization
47.54M
59 days until earnings call
TARA
Price
$3.14
Change
-$0.12 (-3.68%)
Updated
Jun 13 closing price
Capitalization
121.15M
57 days until earnings call
Interact to see
Advertisement

RNXT vs TARA

Header iconRNXT vs TARA Comparison
Open Charts RNXT vs TARABanner chart's image
RenovoRx
Price$1.30
Change-$0.06 (-4.41%)
Volume$139.13K
Capitalization47.54M
Protara Therapeutics
Price$3.14
Change-$0.12 (-3.68%)
Volume$165.45K
Capitalization121.15M
RNXT vs TARA Comparison Chart
Loading...
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNXT vs. TARA commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNXT is a StrongBuy and TARA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (RNXT: $1.30 vs. TARA: $3.14)
Brand notoriety: RNXT and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNXT: 81% vs. TARA: 43%
Market capitalization -- RNXT: $47.54M vs. TARA: $121.15M
RNXT [@Biotechnology] is valued at $47.54M. TARA’s [@Biotechnology] market capitalization is $121.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNXT’s FA Score shows that 0 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • RNXT’s FA Score: 0 green, 5 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, both RNXT and TARA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNXT’s TA Score shows that 2 TA indicator(s) are bullish while TARA’s TA Score has 4 bullish TA indicator(s).

  • RNXT’s TA Score: 2 bullish, 6 bearish.
  • TARA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TARA is a better buy in the short-term than RNXT.

Price Growth

RNXT (@Biotechnology) experienced а -6.47% price change this week, while TARA (@Biotechnology) price change was -5.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

RNXT is expected to report earnings on Aug 13, 2025.

TARA is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($121M) has a higher market cap than RNXT($47.5M). RNXT YTD gains are higher at: 0.775 vs. TARA (-40.530). RNXT has higher annual earnings (EBITDA): -11.6M vs. TARA (-51.1M). TARA has more cash in the bank: 124M vs. RNXT (14.6M). RNXT has less debt than TARA: RNXT (283K) vs TARA (4.23M). RNXT has higher revenues than TARA: RNXT (240K) vs TARA (0).
RNXTTARARNXT / TARA
Capitalization47.5M121M39%
EBITDA-11.6M-51.1M23%
Gain YTD0.775-40.530-2%
P/E RatioN/AN/A-
Revenue240K0-
Total Cash14.6M124M12%
Total Debt283K4.23M7%
FUNDAMENTALS RATINGS
TARA: Fundamental Ratings
TARA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RNXTTARA
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
87%
Bullish Trend 27 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
RNXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRSN0.37N/A
+1.13%
Mersana Therapeutics
CDNS300.00-7.85
-2.55%
Cadence Design Systems
FLS46.46-1.28
-2.68%
Flowserve Corp
CMPO13.66-0.53
-3.74%
CompoSecure
COOK1.80-0.08
-4.26%
Traeger

RNXT and

Correlation & Price change

A.I.dvisor tells us that RNXT and TARA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RNXT and TARA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNXT
1D Price
Change %
RNXT100%
-4.41%
TARA - RNXT
28%
Poorly correlated
-3.68%
IMRX - RNXT
27%
Poorly correlated
-3.06%
DMAC - RNXT
26%
Poorly correlated
-6.41%
VANI - RNXT
25%
Poorly correlated
-3.36%
LXEO - RNXT
24%
Poorly correlated
-3.67%
More

TARA and

Correlation & Price change

A.I.dvisor tells us that TARA and ITRM have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TARA and ITRM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-3.68%
ITRM - TARA
33%
Poorly correlated
-0.52%
BLUE - TARA
32%
Poorly correlated
N/A
CDIO - TARA
30%
Poorly correlated
+2.78%
VTYX - TARA
28%
Poorly correlated
+2.81%
RNXT - TARA
28%
Poorly correlated
-4.41%
More